Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 4,173,000 | 4,864,000 | 4,409,000 | 4,274,000 | 3,896,762 |
| Cost of Goods | 1,156,000 | 3,431,690 | 0 | 0 | 1,207,311 |
| Gross Profit | 3,017,000 | 10,115,110 | 0 | 0 | 2,689,451 |
| Operating Expenses | 2,039,000 | 7,319,690 | 0 | 0 | 1,865,326 |
| Operating Income | 978,000 | -5,886,689 | 4,409,000 | 4,274,000 | 824,436 |
| Interest Expense | -1,000 | -20,000 | 0 | 0 | 0 |
| Other Income | 27,000 | 8,676,369 | -4,409,000 | -4,274,000 | 33,886 |
| Pre-tax Income | 1,006,000 | 2,809,680 | 0 | 0 | 858,322 |
| Income Tax | 123,000 | 99,880 | 0 | 0 | 135,123 |
| Net Income Continuous | 883,000 | 1,157,000 | 13,000 | 1,540,000 | 723,199 |
| Net Income | $883,000 | $1,157,000 | $13,000 | $1,540,000 | $723,199 |
| EPS Basic Total Ops | 0.56 | 0.73 | 0.01 | 0.98 | N/A |
| EPS Basic Continuous Ops | 0.56 | 0.73 | 0.01 | 0.98 | N/A |
| EPS Diluted Total Ops | 0.56 | 0.73 | 0.01 | 0.98 | N/A |
| EPS Diluted Continuous Ops | 0.56 | 0.73 | 0.01 | 0.98 | N/A |
| EBITDA(a) | $1,297,000 | $-5,561,817 | $4,724,233 | $4,591,610 | $1,138,911 |